Amgen’s Kyprolis wins ‘backbone therapy’ FDA nod after trumping Velcade in trial

Carly Helfand

Back in March, Amgen's posted impressive results in a head-to-head with Takeda behemoth –and now, those results have helped it grab an important thumbs up from the FDA.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS